secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytosorbents Corp (CTSO)
CIK:        0001175151
Form:       8-K
Filed at:   2023-09-19T23:59:59+00:00
Accession:  0001104659-23-101952
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoSorbents appoints Kathleen P. Bloch as full-time CFO with new employment agreement
--------------------------------------------------------------------------------

- Bloch returns as CFO effective Sept 2, 2023, replacing former CFO D'Amico after his departure following an investigation.
- Annual base salary of $425,000; eligible for cash bonus up to 45% of base salary at CEO's discretion.
- Equity award: 45,000 RSUs (25k vest immediately, 10k on each of first two anniversaries) and 30,000 options (same vesting schedule).
- Employment agreement runs through Dec 31, 2025 unless terminated earlier.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175151/000110465923101952/0001104659-23-101952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175151/000110465923101952/tm2326325d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-101952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer